Indaptus Therapeutics (INDP) Price-to-Earnings (P/E) Ratio
Price: $0.496
Market Cap: $7.16M
Avg Volume: 419.01K
Market Cap: $7.16M
Avg Volume: 419.01K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Indaptus Therapeutics's P/E ratios across different time periods:
- TTM: -0.31
- Annual: -0.52
- Quarterly: -0.48
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 2.00
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
Indaptus Therapeutics Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-0.31
P/B Ratio (Annual)
2.00
P/S Ratio (Annual)
0.00
Indaptus Therapeutics Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -0.52 | 2.00 | 0.00 |
| 2023 | -0.96 | 1.22 | 0.00 |
| 2022 | -0.87 | 0.49 | 0.00 |
| 2021 | -3.03 | 0.65 | 0.00 |
| 2020 | -1.88 | -28.23 | 0.00 |
| 2019 | -0.35 | 1.46 | 0.00 |
| 2018 | -5.40 | 4.39 | 0.00 |
| 2017 | -3.15 | 1.55 | 0.00 |
| 2016 | -4.88 | 2.87 | 0.00 |
| 2015 | -5.82 | 1.17 | 0.00 |
| 2014 | -254.22 | 152.76 | 0.00 |
| 2013 | -252.47 | 138.38 | 0.00 |
| 2012 | -224.00 | 169.47 | 0.00 |
| 2011 | -135.21 | 131.94 | 0.00 |
| 2010 | -151.44 | 71.37 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for INDP.